|
V3542
|
GSK3004774 |
2138814-32-9 |
GSK3004774 is a novel, potent, nonabsorbable agonist ofCaSR, with anpEC50of 7.3, 6.6 and 6.5 for human, mouse and rat CaSR, respectively. |
|
V3593
|
GSK318689 |
1972617-87-0 |
GSK3186899 (also known as DDD-853651) is a novel and potent inhibitor of cdc-2-related kinase 12 (CRK12), with anEC50of 1.4 μM forL. |
|
V3617
|
GSK3395879 |
2215852-91-6 |
GSK3395879 is a novel, potent, selective and orally bioavailable transient receptor potential vanilloid-4 (TRPV4) antagonist with anIC50of 1 nM for hTRPV4. |
|
V3604
|
GSK376501A |
1010412-80-2 |
GSK376501A is a novel,, potent and selective peroxisome proliferator-activated receptor gamma (PPARγ) modulator that has the potential for the treatment of type 2 diabetes mellitus. |
|
V4394
|
INDACRINONE |
57296-63-6 |
Indacrinone (MK196; Indacrynic acid; Indanone)is an investigational loop diuretic which can be used in patients of gout with hypertension as an antihypertensive because it decreases reabsorption of uric acid. |
|
V4379
|
IPILIMUMAB |
477202-00-9 |
Ipilimumab (trade name Yervoy; also known as MDX-010; BMS-734016) is a fully human monoclonal IgG1κ antibody against the cytotoxic T-lymphocyte antigen-4 (CTLA-4), which is an immune-inhibitory molecule expressed in activated T cells and in suppressor T regulatory cells. |
|
V2120
|
JNJ-18038683 |
851373-91-6 |
JNJ-18038683 is a novel and potent antagonist of 5-Hydroxytryptamine Type 7 (5-HT7) receptor withpKisof 8.19, 8.20 for rat and human 5-HT7in HEK293 cells, respectively. |
|
V2118
|
JNJ-47965567 |
1428327-31-4 |
JNJ-47965567 is a novel, potent,centrally permeable, high affinity and selective antagonist of the purinergic receptor P2X subtype 7 (P2X7), which is a ligand-gated ion channel. |
|
V3546
|
KD-3010 |
934760-90-4 |
KD-3010 is a potent, orally bioactive, and selective agonist of peroxisome proliferator-activated receptordelta(PPARδ)that can be potentially used for the treatment of diabetes and obesity. |
|
V4099
|
KMUP-1 |
81996-46-5 |
KMUP-1, a xanthine derivative, has been demonstrated to modulate K+-channel activity in smooth muscles and is a stimulator of the NO/sGC/cGMP pathway. |
|
V4100
|
KMUP-3 |
421556-16-3 |
KMUP-3, a xanthine derivative, has been demonstrated to modulate K+-channel activity in smooth muscles and is a stimulator of the NO/sGC/cGMP pathway. |
|
V4102
|
KT5823 |
126643-37-6 |
KT5823 (KT-5823),a staurosporine-related analog,is a selective inhibitor of protein kinase G (PKG) with anticancer activity. |
|
V2591
|
L755507 |
159182-43-1 |
L-755,507 isidentified as a potent and selective β3 adrenergic receptor partial agonist with EC50 of 0.43 nM, it displayed > 1000-fold selective over β1- and β2-adrenoceptors (EC50 values are 0.43, 580 and > 10000 nM for activation of cloned human β3-, β1- and β2-adrenoceptors respectively). |
|
V2251
|
LBQ-657 sodium |
149709-44-4 |
Sacubitril (Desethyl Sacubitril) is an active inhibitor of neprilysin (NEP). |
|
V3139
|
LLY-284 |
2226515-75-7 |
LLY-284 (LLY284) is a negative control and tool compound forLLY-283. |
|
V2137
|
LY-309887 |
127228-54-0 |
LY309887 is a novel and potent inhibitor of glycinamide ribonucleotide formyltransferase (GARFT) withKiof 6.5 nM, and has antitumor activity. |
|
V2141
|
LY285434 |
159748-08-0 |
LY285434 is an angiotensin II receptor blocker (antagonist). |
|
V3809
|
LY3104607 |
1795232-22-2 |
LY3104607 is a potent, selective and orally available G Protein-Coupled Receptor 40 (GPR40) agonist with potential antidiabetic application. |
|
V3905
|
MACIMORELIN |
381231-18-1 |
Macimorelin (formerly known as UMV-1843;EP-1572;AEZS-130; JMV1843; trade name:Macrilen) is a synthetic small molecule agonist of growth hormone secretagogue receptor that has been approved to diagnose growth hormone deficiency. |
|
V3904
|
MACIMORELIN ACETATE |
945212-59-9 |
Macimorelin acetate (formerly AEZS-130; EP-1572; JMV-1843; trade name:Macrilen), the acetate salt form of Macimorelin, is a novel and potent synthetic small molecule growth hormone secretagogue receptor agonist approved in 2018 for use in the diagnosis of adult growth hormone deficiency. |